Johnson & Johnson - 63 Year Stock Price History | JNJ

Historical daily share price chart and data for Johnson & Johnson since 1962 adjusted for splits and dividends. The latest closing stock price for Johnson & Johnson as of June 10, 2025 is 156.45.
  • The all-time high Johnson & Johnson stock closing price was 168.80 on April 25, 2022.
  • The Johnson & Johnson 52-week high stock price is 169.99, which is 8.7% above the current share price.
  • The Johnson & Johnson 52-week low stock price is 140.68, which is 10.1% below the current share price.
  • The average Johnson & Johnson stock price for the last 52 weeks is 155.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 153.7936 141.6640 166.2770 139.7360 156.4500 9.98%
2024 150.5325 152.5250 163.3320 138.7730 142.2550 -4.81%
2023 150.4521 164.8930 166.7990 137.7210 149.4450 -8.58%
2022 157.5496 154.6750 168.7990 143.5080 163.4680 5.98%
2021 147.3126 137.6450 159.8230 135.4680 154.2510 11.44%
2020 126.4814 124.9860 138.4190 95.7697 138.4190 10.82%
2019 113.8616 106.3860 125.3880 104.6960 124.9000 16.22%
2018 109.2594 112.8840 123.1170 98.1493 107.4690 -5.13%
2017 103.8781 91.5419 115.8520 88.3177 113.2820 24.43%
2016 88.5700 77.2213 97.7644 73.5862 91.0441 15.33%
2015 75.5193 78.0140 80.8871 69.2179 78.9428 1.14%
2014 74.2524 66.1120 80.9996 62.9092 78.0513 17.34%
2013 61.3912 49.9322 69.4528 49.8617 66.5187 34.62%
2012 46.3230 44.7793 50.6683 42.7758 49.4106 10.85%
2011 42.4021 41.2000 45.3374 38.1578 44.5753 9.89%
2010 40.0204 40.9743 42.1496 36.7306 40.5638 -0.59%
2009 36.0280 37.1734 41.1517 28.7988 40.8033 11.27%
2008 39.1830 39.2668 43.9000 33.9127 36.6708 -7.72%
2007 37.6180 38.5730 40.7503 35.0580 39.7375 3.61%
2006 35.7181 34.9791 39.9160 32.2377 38.3522 12.43%
2005 36.3430 35.0076 38.7924 34.0766 34.1107 -3.36%
2004 30.8179 28.1986 35.4862 27.1387 35.2970 25.17%
2003 28.4442 29.6648 31.5850 26.4724 28.1986 -2.08%
2002 30.6850 31.0477 34.7467 22.2796 28.7962 -7.88%
2001 27.3428 26.8059 32.2484 21.8783 31.2593 13.21%
2000 23.4599 24.2271 27.6107 18.0020 27.6107 12.67%
1999 24.7116 21.7305 27.8899 20.2358 24.5063 11.18%
1998 19.7158 17.0986 23.3894 16.8193 22.0425 27.32%
1997 15.6754 13.0744 17.5913 13.0744 17.3121 32.41%
1996 12.7632 11.0704 14.1256 11.0047 13.0744 16.38%
1995 9.0430 7.1612 12.0231 7.0626 11.2347 56.17%
1994 6.0700 5.9456 7.3254 4.8288 7.1940 22.01%
1993 5.5178 6.5038 6.5038 4.6809 5.8963 -11.14%
1992 6.4832 7.3663 7.6370 5.6662 6.6352 -11.70%
1991 5.8773 4.5840 7.5796 4.2975 7.5140 59.92%
1990 4.1104 3.9107 4.7989 3.3963 4.6986 21.16%
1989 3.2660 2.7273 3.8780 2.7273 3.8780 39.69%
1988 2.6406 2.5479 2.8740 2.2666 2.7762 13.69%
1987 2.8109 2.1973 3.4121 2.1036 2.4419 14.10%
1986 2.0779 1.6918 2.4093 1.5573 2.1402 24.70%
1985 1.4525 1.1619 1.7856 1.1455 1.7163 45.68%
1984 1.1183 1.3331 1.3820 0.9213 1.1781 -11.63%
1983 1.4893 1.6144 1.6673 1.2800 1.3331 -17.63%
1982 1.3321 1.1945 1.6633 1.0599 1.6184 33.67%
1981 1.1140 1.0857 1.2556 0.9295 1.2107 11.65%
1980 0.8627 0.8344 1.0871 0.7229 1.0844 25.87%
1979 0.7839 0.8072 0.8697 0.7039 0.8615 7.45%
1978 0.8343 0.8153 0.9648 0.7161 0.8018 -3.91%
1977 0.7648 0.8493 0.8493 0.6808 0.8344 -1.59%
1976 0.9386 0.9797 1.0450 0.7827 0.8479 -13.10%
1975 0.9671 0.9023 1.0762 0.8018 0.9757 10.98%
1974 1.0716 1.2148 1.2923 0.8167 0.8792 -28.27%
1973 1.2923 1.3969 1.4187 1.1360 1.2257 -13.60%
1972 1.2820 1.0627 1.4363 1.0314 1.4187 32.49%
1971 0.9253 0.6224 1.0749 0.6224 1.0708 72.82%
1970 0.5593 0.6360 0.6441 0.4063 0.6196 -5.01%
1969 0.4632 0.3832 0.6523 0.3669 0.6523 69.03%
1968 0.3206 0.3261 0.3859 0.2709 0.3859 16.06%
1967 0.2775 0.2041 0.3469 0.2005 0.3325 61.02%
1966 0.2098 0.2114 0.2416 0.1690 0.2065 -0.72%
1965 0.1676 0.1344 0.2108 0.1344 0.2080 54.07%
1964 0.1269 0.1261 0.1438 0.1159 0.1350 9.58%
1963 0.1085 0.0903 0.1433 0.0897 0.1232 39.21%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $373.495B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $733.273B 56.23
AbbVie (ABBV) United States $334.133B 18.42
Roche Holding AG (RHHBY) Switzerland $260.539B 0.00
Novartis AG (NVS) Switzerland $249.308B 14.24
Merck (MRK) United States $199.200B 10.18
Pfizer (PFE) United States $136.278B 7.47
Sanofi (SNY) France $122.010B 12.02
Bayer (BAYRY) Germany $29.591B 6.02
Innoviva (INVA) United States $1.355B 14.20
Novo Nordisk (NVO) Denmark $0.000B 22.33